Google, Facebook, Apple invite nominations for 2014 'Breakthrough Prize'

Singapore: Breakthrough Prize in Life Sciences Foundation has opened its process of online nomination for the 2014 prize...

September 4, 2013 | Wednesday | News
Bionomics cancer trial shows +ve results

Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its...

February 3, 2014 | Monday | News
New drug slows cancer significantly

Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dr...

December 6, 2012 | Thursday | News
Shionogi launches London headquarter

Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be c...

July 6, 2012 | Friday | News
Tetraphase antibiotic gets FDA QIDP designation

Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candida...

July 22, 2013 | Monday | Regulatory
Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer

Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...

April 24, 2014 | Thursday | News
Novartis to ship 30 mn flu vaccine to US

Singapore: Novartis plans to ship around 30 million doses of its influenza vaccines including Fluvirin and Flucelvax to ...

April 24, 2013 | Wednesday | News
FDA warns Genentech researcher for trial data validity

Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular d...

July 19, 2013 | Friday | News
Pall to acquire Atmi for $185 million

Singapore: Pall Corporation, a developer of filtration, separation and purification technology, has decided to acquire A...

February 3, 2014 | Monday | News
Now 9-yr-old girls can use Cervarix for cancer

Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, prem...

May 7, 2013 | Tuesday | Regulatory
Novotech to support drug development in Korea

Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to...

July 5, 2014 | Saturday | News
Xiangxue Pharma acquires rights for Kinex KX02

Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...

May 22, 2012 | Tuesday | News
Alchemia appoints new chairman

Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-exe...

February 11, 2014 | Tuesday | Influencers
Bionomics, Merck Serono end agreement

Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended t...

June 15, 2012 | Friday | News
Chinese, Hong Kong scientists map H7N9 risk infection

Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...

May 8, 2013 | Wednesday | News
AstraZeneca, Alchemia sign $240 mn drug deal

Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...

April 23, 2013 | Tuesday | News
Takeda gets Japanese NDA approval for obesity drug

Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...

September 23, 2013 | Monday | News
Lilly reveals phase III trial data on back pain

Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rD...

August 8, 2012 | Wednesday | News